miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs

Frontiers in Genetics

Volumn 4, Issue APR, 2013, Pages

  Lupini, Laura ^a   Bassi, Cristian ^a   Ferracin, Manuela ^a   Bartonicek, Nenad ^b   D'Abundo, Lucilla ^a   Zagatti, Barbara ^a   Callegari, Elisa ^a   Musa, Gentian ^a   Moshiri, Farzaneh ^a,c   Gramantieri, Laura ^d   Corrales, Fernando J ^e   Enright, Anton J ^b   Sabbioni, Silvia ^a   Negrini, Massimo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Gene targets; Microarray; microRNA; miR 221; Sylamer

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA CATENIN; GINSENOSIDE RB 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 1; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA 221; MYC PROTEIN; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; WEE1 PROTEIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; NEOPLASM; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 84973530978     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00064     Document Type: Article

References (26)

1. Bartonicek, N., and Enright, A. J. (2010). SylArray: a web server for automated detection of miRNA effects from expression data. Bioinformatics 26, 2900-2901.
2. Callegari, E., Elamin, B. K., Giannone, F., Milazzo, M., Altavilla, G., Fornari, F., et al. (2012). Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 56, 1025-1033.
3. Felli, N., Fontana, L., Pelosi, E., Botta, R., Bonci, D., Facchiano, F., et al. (2005). MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. U.S.A. 102, 18081-18086.
4. Ferracin, M., Gafa, R., Miotto, E., Veronese, A., Pultrone, C., Sabbioni, S., et al. (2008). The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile. J. Pathol. 214, 594-602.
5. Fornari, F., Gramantieri, L., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., et al. (2008). MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27, 5651-5661.
6. Fu, X., Wang, Q., Chen, J., Huang, X., Chen, X., Cao, L., et al. (2011). Clinical significance of miR-221 and its inverse correlation with p27(Kip1) in hepatocellular carcinoma. Mol. Biol. Rep. 38, 3029-3035.
7. Galardi, S., Mercatelli, N., Giorda, E., Massalini, S., Frajese, G. V., Ciafre, S. A., et al. (2007). miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 282, 23716-23724.
8. Garofalo, M., Di Leva, G., Romano, G., Nuovo, G., Suh, S. S., Ngankeu, A., et al. (2009). miR-221and222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498-509.
9. Gottardo, F., Liu, C. G., Ferracin, M., Calin, G. A., Fassan, M., Bassi, P., et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25, 387-392.
10. Gramantieri, L., Fornari, F., Callegari, E., Sabbioni, S., Lanza, G., Croce, C. M., et al. (2008). MicroRNA involvement in hepatocellular carcinoma. J. Cell Mol. Med. 12, 2189-2204.
11. Gramantieri, L., Fornari, F., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., et al. (2009). MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin. Cancer Res. 15, 5073-5081.
12. Lee, E. J., Gusev, Y., Jiang, J., Nuovo, G. J., Lerner, M. R., Frankel, W. L., et al. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120, 1046-1054.
13. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
14. le Sage, C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E., Mangiola, A., et al. (2007). Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26, 3699-3708.
15. Liu, K., Li, G., Fan, C., Diao, Y., Wu, B., and Li, J. (2012). Increased expression of MicroRNA-221 in gastric cancer and its clinical significance. J. Int. Med. Res. 40, 467-474.
16. Maragkakis, M., Reczko, M., Simossis, V. A., Alexiou, P., Papadopoulos, G. L., Dalamagas, T., et al. (2009). DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 37, W273-W276.
17. Medina, R., Zaidi, S. K., Liu, C. G., Stein, J. L., van Wijnen, A. J., Croce, C. M., et al. (2008). MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res. 68, 2773-2780.
18. Mercatelli, N., Coppola, V., Bonci, D., Miele, F., Costantini, A., Guadagnoli, M., et al. (2008). The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE 3:e4029. doi: 10.1371/journal.pone.0004029
19. Nikolsky, Y., Ekins, S., Nikolskaya, T., and Bugrim, A. (2005). A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 158, 20-29.
20. Park, J. K., Kogure, T., Nuovo, G. J., Jiang, J., He, L., Kim, J. H., et al. (2011). miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 71, 7608-7616.
21. Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., et al. (2010). miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 264-269.
22. Quintavalle, C., Garofalo, M., Zanca, C., Romano, G., Iaboni, M., del Basso De Caro, M., et al. (2012). miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPmu. Oncogene 31, 858-868.
23. van Dongen, S., Abreu-Goodger, C., and Enright, A. J. (2008). Detecting microRNA binding and siRNA off-target effects from expression data. Nat. Methods 5, 1023-1025.
24. Visone, R., Russo, L., Pallante, P., De Martino, I., Ferraro, A., Leone, V., et al. (2007). MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr. Relat. Cancer 14, 791-798.
25. Zhang, C., Zhang, J., Zhang, A., Wang, Y., Han, L., You, Y., et al. (2010a). PUMA is a novel target of miR-221/222 in human epithelial cancers. Int. J. Oncol. 37, 1621-1626.
26. Zhang, C. Z., Zhang, J. X., Zhang, A. L., Shi, Z. D., Han, L., Jia, Z. F., et al. (2010b). MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol. Cancer 9:229. doi: 10.1186/1476-4598-9-229